Synthesis and evaluation of antioxidant activity of new quinoline-2-carbaldehyde hydrazone derivatives: bioisosteric melatonin analogues

References

• Suzen S. Recent developments of melatonin related antioxidant compounds. Com Chem High T Synt 2006;9:409–19
   PubMed Web of Science ®Google Scholar
• Suzen S. Antioxidant activities of synthetic indole derivatives and possible activity mechanisms. In: Khan MTH, ed. Heterocyclic chemistry, bioactive heterocycles, Vol. 11. Berlin, Heidelberg: Spinger-Verlag; 2007:145–78 (Chapter V)
   Google Scholar
• Suzen S. Evaluation synthetic melatonin analogue antioxidant compounds. In: Srinivasan V, Gobbi G, Shillcutt DS, Suzen S, eds. Melatonin: therapeutic value and neuroprotection. Oxford: CRC Press, Taylor and Francis; 2014:250–68
   Google Scholar
• Karaaslan C, Kadri H, Coban T, et al. Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles. Bioorg Med Chem Lett 2013;23:2671–4
   PubMed Web of Science ®Google Scholar
• Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47–95
   PubMed Web of Science ®Google Scholar
• Suzen S, Tekiner-Gulbas B, Shirinzadeh H, et al. Antioxidant activity of indole-based melatonin analogues in erythrocytes and their voltammetric characterization. J Enz Inhib Med Chem 2013;28:1143–55
   PubMed Web of Science ®Google Scholar
• Yilmaz Ad, Coban T, Suzen S. Synthesis and antioxidant activity evaluations of melatonine based analogue indole-hydrazide/hydrazone derivatives. J Enz Inhib Med Chem 2012;27:428–36
   PubMed Web of Science ®Google Scholar
• Gurkok G, Coban T, Suzen S. Melatonin analogue new indole hydrazide/hydrazone derivatives with antioxidant behavior: synthesis and discussion on structure activity relationships. J Enzym Inhib Med Chem 2009;24:506–15
   PubMed Web of Science ®Google Scholar
• Shirinzadeh H, Eren B, Gurer-Orhan H, et al. Novel indole-based analogs of melatonin: synthesis and in vitro antioxidant activity studies. Molecules 2010;15:2187–202
   PubMed Web of Science ®Google Scholar
• Mathé-Allainmat M, Andrieux J, Langlois M. Recent developments in melatonin receptor ligands. Expert Opin Therapeut Patents 1997;7:1447–58
   Web of Science ®Google Scholar
• Iakovou K, Varvaresou A, Kourounakis AP, et al. Design, synthesis and biological evaluation of novel conformationally restrained melatoninergic analogs. J Pharm Pharmacol 2002;54:147–56
   PubMed Web of Science ®Google Scholar
• Suzen S. Melatonin and synthetic analogs as antioxidants. Curr Drug Deliv 2013;10:71–5
   PubMed Web of Science ®Google Scholar
• Ancizu S, Castrillo N, Pérez-Silanes S, et al. New quinoxaline derivatives as potential MT1 and MT2 receptor ligands. Molecules 2012;17:7737–57
   PubMed Web of Science ®Google Scholar
• Puskullu MO, Tekiner B, Suzen S. Recent studies of antioxidant quinoline derivatives. Mini Rev Med Chem 2013;13:365–72
   PubMed Web of Science ®Google Scholar
• Larsen RD, Corley EG, King AO, et al. Practical route to a new class of LTD4 receptor antagonists. J Org Chem 1996;61:3398–405
   Web of Science ®Google Scholar
• Roma G, Braccio MD, Grossi G, et al. 1,8-Naphthyridines IV, 9-substituted N,N-dialkyl-5-(alkylamino or cycloalkyl amino) [1,2,4] triazolo [4,3-a] [1,8] naphthyridine-6-carboxamides, new compounds with antiaggressive and potent anti- inflammatory activities. Eur J Med Chem 2000;35:1021–35
   PubMed Web of Science ®Google Scholar
• Chen YL. Fang KC, Sheu JY, et al. Synthesis and antibacterial evaluation of certain quinolone derivatives. J Med Chem 2001;44:2374–7
   PubMed Web of Science ®Google Scholar
• Kauffman GS, Harris GD, Dorow RL, et al. An efficient chiral moderator prepared from inexpensive (+)-3-carene: synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963. Org Lett 2000;2:3119–21
   PubMed Web of Science ®Google Scholar
• Kumar S, Bawa S, Gupta H. Biological activities of quinoline derivatives. Mini Rev Med Chem 2009;9:1648–54
   PubMed Web of Science ®Google Scholar
• Subashini R, Roopan SM, Khan FN. Synthesis and free radical scavenging property of some quinoline derivatives. J Chil Chem Soc 2010;55:317–19
   Web of Science ®Google Scholar
• Panteleon V, Kostakis IK, Marakos P, et al. Synthesis of some new spiropyranoquinolines and evaluation of their free radical scavenging activity. Chem Pharm Bull (Tokyo) 2009;57:446–52
   PubMed Web of Science ®Google Scholar
• Korrichi L, Dalila B, Dalila S. Quinolines antioxydant activity structure activity relation-ship. Eur J Biol Sci 2009;1:32–6
   Google Scholar
• Sankaran M, Kumarasamy C, Chokkalingam U, Mohan PS. Synthesis, antioxidant and toxicological study of novel pyrimido quinoline derivatives from 4-hydroxy-3-acyl quinolin-2-one. Bioorg Med Chem Lett 2010;20:7147–51
   PubMed Web of Science ®Google Scholar
• Nayyar A, Malde A, Coutinho E, Jain R. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives. Bioorg Med Chem 2006;14:7302–10
   PubMed Web of Science ®Google Scholar
• Kidwai M, Negi N, Gupta SD. Synthesis and antifertility activity of 1,5-diaryl-3(3′-indolyl)formazans. Chem Pharm Bull (Tokyo) 1994;42:2363–4
   PubMed Web of Science ®Google Scholar
• Puntarulo S, Cederbaum AI. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic Biol Med 1998;24:1324–30
   PubMed Web of Science ®Google Scholar
• Hassoun EA, Roche VF, Stohs JS. Release of enzymes by ricin from macrophages and Chinese hamster ovary cells in culture. Toxicol Methods 1993;3:119–29
   Web of Science ®Google Scholar
• Moss DW, Henderson AR, Kochmar JR. Enzymes. In: Tietz NW, ed. Textbook of clinical chemistry. Philadelphia, USA: WB Saunders; 1986:619–63
   Google Scholar
• Lautraite S, Bigot-Lasserre D, Bars R, Carmichael N. Optimisation of cell-based assays for medium throughput screening of oxidative stress. Toxicol In Vitro 2003;17:207–20
   PubMed Web of Science ®Google Scholar